{"paper_id":"b8575567-a3fe-48ee-ac77-9f7e79534d58","body_text":"Inflammation is a protective host response to infection or tissue injury, involving coordinated processes such as vasodilation and immune cell recruitment to the injury site. However, dysregulated inflammatory responses contribute to many acute and chronic diseases. Among key inflammation regulators, nuclear factor kappa B (NF-κB) plays a central role by controlling the expression of multiple pro-inflammatory genes in both innate and adaptive immune cells [ 1 ]. Consequently, cell-based assays targeting NF-κB signaling have become valuable pharmacological tools for identifying novel anti-inflammatory agents. RAW-Blue™ macrophages, derived from RAW 264.7 cell line, constitutively express a secreted embryonic alkaline phosphatase (SEAP) reporter gene under the control of NF-κB and AP-1 transcription factors. After stimulation of pattern recognition receptors, including Toll-like receptors (TLRs), these transcription factors activate SEAP secretion [ 2 ].\nMedicinal plants remain an important source of bioactive compounds with anti-inflammatory potential. Among them are species of the genus Salvia, one of the most extensive in the Lamiaceae family, comprising more than 900 species worldwide. Species in this genus have diverse medicinal uses, including sedative, hypnotic, antinociceptive, acetylcholinesterase inhibitor, anticonvulsant, antipyretic, anti-inflammatory, smooth muscle relaxant, neuroprotective, and antihypertensive activities [ 3 ]. Sufficient pharmacological information exists on the anti-inflammatory properties of the Salvia genus [ 4 , 5 ], which has been recognized as a rich source of terpenoids, flavonoids, phenolic acids, and other specialized metabolites with pharmacological activity [ 6 , 7 ]. Several studies have shown that species of this genus have anti-inflammatory activity in macrophage cultures. One example is  S. miltiorrhiza;  reports of its anti-inflammatory activity are extensive, demonstrating the plant’s ability to reduce inflammation across various models and pharmacological targets [ 8 ]. Notably, a study reported that the plant extract and certain terpenes (tanshinone IIA, miltirone, and cryptotanshinone) exert an anti-inflammatory effect by reducing nitric oxide (NO) release in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages [ 9 ]. From the medicinal species  S. multicaulis —native to Central and Eastern Asia and traditionally used for wound healing, as an anti-inflammatory, and for pain relief—a terpenoid named salvimulticanol was isolated; this compound is capable of suppressing LPS-induced NO release in RAW264.7 macrophages in a concentration-dependent manner [ 10 ]. Another terpenoid, salviplenoid A, isolated from S. plebeian, a medicinal plant used in China to treat inflammation, reduced levels of NO, iNOS, TNF-α, and COX-2 in LPS-stimulated RAW264.7 macrophages, an effect associated with inhibition of NF-κB transcriptional activity [ 11 ].\nMéxico is one of the principal centers of diversification of the genus, harboring many native species [ 4 , 12 ]. For example,  Salvia elegans  Vahl., also known as “red-flowered myrtle,” “English myrtle,” or jetcho deni (Otomí), is native to Mexico and Central America. This semi-woody perennial herb reaches 1.0 to 1.5 m in height and inhabits temperate climates at elevations of 2280 to 3100 m, commonly found in pine, oak, and mixed forests. It prefers well-drained, moist soils with an acidic pH and variable texture, primarily on hillside slopes. In Mexico, documented distributions include Sonora, Chihuahua, Durango, Michoacán, Hidalgo, the State of Mexico, Morelos, Mexico City, Veracruz, and Oaxaca.  S. elegans  has notable ethnobotanical uses in central Mexico as follows: leaf infusions are taken for abdominal pain, it is used as a mild hypnotic (either by placing sprigs under pillows or as an infusion), root and stem poultices are applied for edema and trauma, and in Puebla, it is employed for gynecological and obstetric purposes such as postpartum recovery and newborn bathing [ 13 ]. This plant is traditionally used to treat inflammatory conditions, including traumatic edema [ 12 ]. Nevertheless, despite its traditional use, the direct anti-inflammatory activity of  S. elegans  has not been experimentally evaluated using validated pharmacological models.\nPrevious pharmacological studies have demonstrated antihypertensive activity through inhibition of angiotensin-converting enzyme (ACE) and antagonism of angiotensin II [ 14 , 15 ], as well as anxiolytic and antidepressant effects in behavioral animal models [ 16 , 17 ]. In addition, administration of its ethyl acetate extract and derived fractions reduced pro-inflammatory cytokine concentrations in different organs of mice with diet-induced obesity [ 18 ].\nPhytochemical studies of  S. elegans  have isolated and identified several secondary metabolites, including terpenoids, flavonoids, phenylpropanoids, and sterols [ 15 , 16 , 17 ]. Among these metabolites, rosifoliol/agarospirol [ 19 ] and isosakuranetin-5-O-rutinoside [ 17 ] have been previously reported. However, the metabolites responsible for, or contributing to, the anti-inflammatory activity of  S. elegans  have not yet been identified, and the relationship between its phytochemical composition and anti-inflammatory effects remains poorly understood.\nTherefore, this study aimed to characterize the anti-inflammatory activity of the ethyl acetate extract of  S. elegans  (SeAcOEt) by pharmacologically evaluating its bioactive fractions and major isolated metabolites using complementary in vivo and in vitro experimental models. We used the TPA-induced mouse ear edema model to determine the contribution of the extract, fractions, and isolated metabolites to overall anti-inflammatory activity. In addition, the major isolated metabolites, compound 4 (7α-hydroxysandaracopimaric acid) and the rosifoliol/agarospirol mixture (TM; compounds 1/2), were evaluated for their effects on NF-κB/AP-1 signaling by quantifying SEAP reporter activity in LPS-stimulated RAW-Blue™ macrophages.\n\nFraction SeFA obtained from the chromatographic fractionation of the ethyl acetate extract (SaAcOE) was analyzed by gas chromatography-mass spectrometry (GC-MS) (see  Figure S1 ) and allowed us to identify that this fraction mainly contains the terpenes called 2-(2R,4aS,8R)-4a,8-dimethyl-2,3,4,4a,5,6,7,8-octahydronaphthalen-2-yl)propan-2-ol, known as rosifoliol ( 1 ) in 25.2% and 2-(2R,5R,10R)-6,10-dimethylspiro[4.5]dec-6-en-2-yl)propan-2-ol or agarospirol ( 2 ) at 19.5%—this mixture is called TM. Compounds that had already been previously identified in this species are presented [ 20 ].\nChromatographic fractionation of SeFB yielded compound ( 3 ) as a colorless powder, which was compared by HPLC with a standard ursolic acid sample (UA,  3 ). ESI-MS of positive ions revealed quasi-molecular peaks at  m / z  455.8 [M] +  for the molecular formula C 30 H 48 O 3  ( m / z  = 456.36) and 395 [M-H 2 O-CO 2  + H] +  for the molecular formula C 29 H 46  ( m / z  = 394.3) (see  Figures S2 and S3 ).\nCompound  4  was a white, amorphous solid (1170 mg), soluble in methanol with a melting point of 91 °C. In the UV light spectrum, the compound showed a λ max  192 nm, characteristic of terpene. The  13 C NMR spectrum showed twenty signals, which correspond to a diterpene, and according to the DEPT experiment, five are quaternary, five methine, seven methylene and three methyl. The  1 H NMR spectrum showed the following two signals corresponding to a vinylic ABX system: δ 5.8 (1H, dd,  J  = 10.6, 17.5 Hz), 4.91 (1H, dd,  J  = 1.4, 10.6 Hz) and 4.99 (1H, dd,  J  = 1.4, 17.5 Hz) assigned a H-15, H-16a and H-16b respectively, and a A system [δ 5.51 (H, d,br,  J  = 1.4 Hz) assigned a H-14. According to the HMBC experiment, H-15 (δ 5.8) correlates with three carbon bands at δ 135.1, 38.6 and 26.4, assigned to C-14, C-13 and C-17, respectively. The orientation of the methyl group Me-17 (δH 1.05) in the β position was established by the field interaction observed in the NOESY experiment with the hydrogens of H-20 (δH 0.85), H-12a (δH 1.5), H-12b (δH 1.4) and H-14 (δH 5.5). Additionally, a proton NMR observed an oxygen base at δ 4.1 (dd,  J  = 2.35, 2.82) assigned to H-7 and which correlates in HSQC with carbon at δ 73.86, the orientation of the hydroxyl group in the α position at C-7 and the hydrogen H-7 in the β position (δH 4.10) was evidenced by the NOESY interaction of H-7 observed among H-20 (δH 0.85), H-14 (δH 5.5), H-6a (δH 1.68), and H-6b (δH 1.42) ( Figure 1 ).\nAccording to these spectroscopic data analyses ( Table 1 ) and the comparison with data described in the literature [ 21 ], this compound corresponds to a diterpene of isopimaric acid type with a hydroxyl group in position α in C-7, denominated 7α-hydroxy-8(14),15-isopimaradien-18-oic acid, also known as 7α-hydroxysandaracopimaric acid ( 4 , 180.7 mg,  Figure 1  and Figure 4). This compound has been identified in the bark of  Cryptomeria japonica  and is the first time isolated from  S. elegans .\nAccording to the HPLC analysis ( Figure 2 ) of the ethyl acetate extract (SeAcOE), the concentration of ursolic acids ( 3 , Rt 13.5 min) and 7α-hydroxysandaracopimaric ( 4 , Rt 9.0 min) was 0.039 and 0.045 mg/g, respectively. While in the SeFB fraction, these compounds are found at a concentration of 0.43 mg/g of  3  and 0.19 mg/g of  4 .\nWhen processing the SeFC fraction, the following two flavones were purified: jaceosidin  5  and isosakuranetin-5-O-rutinoside  6 , with retention times of 19.2 and 14.4 min, respectively ( Figure 3 ).\nCompound ( 5 ) was isolated as a yellow powder with a melting point of 260–262 °C. In the UV light spectrum, the compound showed a λ max  213.4, 254, 273 and 344 nm, characteristic of a flavone. The  1 H NMR spectra of  5  showed the following three systems: aromatics A system [δ 6.71 (1H, s, H-8)]; signals other aromatic ABX system [δ 7.43 (1H, d, 1.9 Hz, H-2′), 6.9 (1H, d, 8.9 Hz, H-5′) and 7.45 (1H, dd, 1.95, 7.8 Hz, H-6′)] and double bond system in δ 6.85 (1H, s, H-3), which indicates a flavone nucleus called 6-hydroxiluteolin. Additionally, two proton signals of oxygenated base were observed in δ 3.73 and 3.91 that integrate for three protons and correlate in the HSQC with the carbon signal in δ 56.39 and 60.0 respectively, characteristic of two methoxyls. The methoxyl position was defined unambiguously to be at C-6 (δ 131.86) due to the long-range correlation (HMBC) between protons OCH 3  (δ 3.73) and C-3′ (δ 149.81) with OCH 3  (δ 3.91) respectively. Based on this information, the natural product was identified as jaceosidin. Based on direct comparison of spectroscopic data (see  Table 2 ) described in the literature, this compound was identified as 4′,5,7-trihydroxy-3′,6-dimethoxyflavone or named jaceosidin ( 5 ,  Figure 4 ) [ 21 ].\nCompound ( 6 ,  Figure 4 ) was isolated as an amorphous solid and identified as isosakuranetin-5-O-rutinoside. Structural identification of this flavanone was compared directly to a previously isolated sample and for HLPC ( Figure 1  and  Figure 4 ) [ 17 ].\nThe edema caused by TPA application in the mouse ear generated a differential of up to 12.6 ± 1.2 mg between the ear without damage and the inflamed ear. Treatment with topical administration of indomethacin (INDO) 1 mg/ear caused a decrease of about 91.2% in inflammation, a statistically significant decrease compared with TPA (1.1 ± 0.4 mg). Administration of 1 mg/ear of the  S. elegans  ethyl acetate extract (SeAcOEt) resulted in a decrease in edema (1.6 ± 1.0 mg), corresponding to an anti-inflammatory effect of 87.3%, which was significantly different from TPA data ( Figure 5 ).\nThe fractionation of the SeAcOEt extract generated three fractions ( Figure 5 ), where the SeFA corresponds to the least polar fraction, containing diterpenes and fatty acids. From the SeFA fraction (69.1%), the mixture of terpenes (TM)  1  and  2  was separated, which induced an inhibition of 55.7% (inflammatory edema of 5.5 ± 1.08 mg).\nThe SeFB fraction decreased the edema by 0.677 ± 2.1 mg, which represented a 97.4% inhibition of inflammation. It should be mentioned that the composition of this fraction mainly includes UA  3  and 7α-hydroxysandaracopimaric acid  4 , as observed in the chromatogram shown in  Figure 2 .\nFraction SeFC showed a moderate anti-inflammatory effect. It had the capacity to reduce edema up to 4.4 ± 1.7 mg, representing 65.6% inhibition of inflammation, and was identified in this fraction as jaceosidin, the major compound. Finally, the evaluation of the anti-inflammatory effect of isosakuranetin-5-O-rutinoside  6  was performed and showed no statistically significant difference with respect to the damage group ( p  > 0.05, VEH).\nBecause the SeFB fraction showed one of the most significant anti-inflammatory effects, a dose–effect curve was performed ( Figure 6 ). In this dose–response behavior, the pharmacological constants were calculated as follows: E max  = 102% and ED 50  = 0.092 mg/ear. It was also possible to establish that this fraction contained UA ( 3 ) and 7α-hydroxysandaracopimaric acid ( 4 ); then, a dose–response curve was performed with the new compound  4 , with E max  = 17% and ED 50  = 1.087 mg/ear ( Figure 7 ).\nBased on these results, a concentration–response curve in the RAW-Blue TM  cells in vitro assay was performed for  4  and  1 / 2  (TM). The data analysis indicates inhibition of NF-κB activation by both substances, with pharmacodynamic parameters of Emax = 28.9% and IC 50  = 4.08 mg/mL for TM; meanwhile, for compound  4 , the values were Emax = 36.6% and IC 50  = 37.0 mg/mL ( Figure 8 ).\n\nThe present study demonstrates that  S. elegans  Vahl. exhibits local anti-inflammatory activity, which could be attributable to a synergistic combination of terpenoid and flavonoid compounds. The bio-guided investigation using the TPA-induced mouse ear edema model allowed the isolation of the following six main metabolites: mixture 1/2, 3, 4, 5, and 6. The identification of these compounds confirms that this species shares the pharmacological potential observed in other members of the Salvia genus, such as  S. connivens  and  S. plebeia , in which terpenoid and flavonoid extracts have been shown to inhibit pro-inflammatory mediators such as COX-2 and to inhibit NF-κB signaling [ 22 , 23 ].\nFor the identification of the active compounds in  S. elegans , the TPA-induced mouse ear edema model was employed; this compound induces a marked inflammatory response in the skin characterized by neutrophil infiltration [ 24 ]. TPA activates phospholipase A 2  (PLA 2 ), promoting the release of arachidonic acid (AA) and consequently stimulating prostaglandin synthesis [ 25 ]. The biochemical cascade that converts AA into prostaglandins is triggered by diverse stimuli, including mechanical stress, heat, chemical injury, bacterial products, and pro-inflammatory cytokines [ 26 ]. Activation of this eicosanoid pathway involves the NF-κB signaling pathway, which depends on COX-2 expression induced by TPA [ 27 , 28 ]. INDO, a known COX-2 inhibitor, was used as a positive control; its predictable anti-inflammatory effect confirms and validates the reliability of the experimental model [ 29 ]. This study shows that SeFB has a greater effect than INDO, which may be because this natural product contains COX-2-inhibiting compounds such as ursolic acid ( 3 ), a well-documented triterpene previously reported to show significant anti-inflammatory activity in the TPA-induced ear edema model, with an ED 50  value of 0.02 mg/ear [ 22 ], and also mediated the direct inhibition of COX-2 and the nuclear translocation of NF-κB [ 28 , 29 ]. Therefore, SeFB could act through multiple anti-inflammatory mechanisms via its secondary metabolites, producing a greater effect than INDO. This suggests a pharmacological interaction among the compounds in the fraction. Consequently, this superior effect could be investigated using isobologram assays with isolated compounds. This approach would help determine whether the components in SeFB exhibit synergy.\nFrom this same fraction, 7α-hydroxysandaracopimaric acid was isolated for the first time from this species, and its anti-inflammatory activity was evaluated. The results demonstrated that this new compound effectively reduced ear edema. Furthermore, previous studies have described related pimarane diterpenes, such as pimaradienoic acid, an isomer of pimaric acid, which were shown to inhibit carrageenan-induced leukocyte and neutrophil recruitment in the peritoneal cavity, as well as to reduce carrageenan-induced paw edema [ 30 ]. These findings suggest that the pimarane structural framework plays a crucial role in the anti-inflammatory activity of this class of compounds. The prediction analysis with 7α-hydroxysandaracopimaric acid, isolated for the first time from  S. elegans , exhibited anti-inflammatory activity, possibly mediated through the modulation of nuclear receptors of the PPAR type (α and γ). According to pharmacological predictions performed using SwissTargetPrediction, this diterpene interacts with key genes and proteins involved in lipid homeostasis and immunometabolic regulation, such as PPARG, PPARA, and MME, as well as prostaglandin receptors PTGER2, PTGER4, and PTGDR ( Figure 9 ) [ 31 ]. These interactions suggest that 7α-hydroxysandaracopimaric acid may exert a pleiotropic effect, modulating both acute inflammation and chronic processes associated with metabolic and cardiovascular disorders. Activation of PPARγ is associated with the suppression of SEAP activation for NF-κB signaling and COX-2, which is consistent with the experimental model of TPA-induced edema inhibition. The presence of ursolic acid ( 3 ) reinforces the anti-inflammatory profile of SeFB and the SeAcOEt extract of  S. elegans  and contributes significantly (≈59%) to the total observed effect. The combined action of this compound with 7α-hydroxysandaracopimaric acid ( 4 ) suggests a biochemical synergy between these terpenes.\nJaceosidin ( 5 ), isolated from SeFC, also reported in this work for the first time in  S. elegans , was not tested here for anti-inflammatory effect, due to this substance has been evaluated in biological models of inflammation, is recognized for its ability to suppress the expression of COX-2 and the production of TNF-α and IL-1β, as well as to inhibit the activation of NF-κB signaling [ 32 , 33 , 34 ].\nIn contrast, the isosakuranetin-5-O-rutinoside ( 6 ), present in the same fraction, showed no local anti-inflammatory effect at doses of 1 mg/ear, which may be attributed to structural differences affecting its interaction with enzymes and receptors involved in the inflammatory response, such as the absence of a hydroxyl group at the C-7 position [ 35 ], contrary to what is reported for its isomer sakuranetin, which did have the anti-inflammatory effect, due to diminishing the neutrophil recruitment to the peritoneal cavity of mice pretreated prior with carrageenan. In addition, it was mentioned that the activity was due to the presence of hydroxyl group at C-7 and methoxyl group at C-5 at sakuranetin [ 36 ] and then isosakuranetin-5-O-rutinoside isolated from  S. elegans  [ 10 ] has not these chemical characteristics.\nThe SeFA, from which the diterpenes rosifoliol ( 1 ) and agarospirol ( 2 ) could be isolated—the first one has reports of anti-inflammatory and cytotoxic activity; rosifoliol is a component of  Helichrysum microphyllum , which has antioxidant activity in vitro [ 37 ].\nFrom a molecular perspective, prediction analyses suggest that several of the identified metabolites act on relevant pharmacological targets. For instance, agarospirol and rosifoliol showed affinity for CYP19A1 (aromatase) and AR (androgen receptor), implying a potential modulatory role in the synthesis of sex steroids and, therefore, possible therapeutic applications in hormone-dependent diseases such as breast cancer, endometriosis, or benign prostatic hyperplasia [ 38 , 39 ].\nIn the case of rosifoliol, its potential interaction with NR1H3 (liver X receptor alpha, LXRα) and with genes such as SREBF2 and NPC1L1 suggests involvement in the regulation of cholesterol metabolism and lipid homeostasis [ 40 , 41 ]. Since activation of LXRα induces the transcription of genes involved in cholesterol efflux and the suppression of NF-κB-dependent inflammatory processes, rosifoliol could indirectly contribute to the systemic anti-inflammatory activity of the extract, in addition to offering potential benefits in pathologies such as atherosclerosis and dyslipidemia ( Figure 9 ) [ 42 ].\nBased on the above findings, the anti-inflammatory effect of the SeAcOEt extract is primarily attributed to the presence of ursolic acid  3 , 7α-hydroxysandaracopimaric acid  4 , jaceosidin  5 , and the rosifoliol/agarospirol  1 / 2 , TM. The concentrations of these compounds in the extract were determined to be 0.039, 0.045, 0.0097, and 0.019 mg per mg of extract, respectively. The IC 50  values for these compounds in the TPA-induced mouse ear inflammation assay were 0.02, 1.087, and 0.0033 mg, respectively [ 35 , 43 ].\nThe TM exhibited an IC 50  value of 4 μg/mL, although this was determined in a different biological model—specifically, the inhibition of the activation of NF-κB and AP-1 in RAW-Blue TM  cells cultures. Similarly, the IC 50  value reported for jaceosidin was obtained in a pharmacological model distinct from TPA-induced inflammation; however, it provides a useful approximation of the expected anti-inflammatory potency of this compound.\nIf the extract’s effect results solely from a summative pharmacological interaction among its components, the relative contribution of each compound can be estimated as follows: 59.1% for  3 , 2.8% for  4 , 2.7% for  5 , and 5.0% for the  1/2  TM. The total calculated summative effect of 90.0% closely approximates the 87.3% inhibition observed for the SeAcOEt extract. Similarly, since the concentrations of the active compounds in fraction SeFB ursolic acid and 7α-hydroxysandaracopimaric acid were quantified at 0.43 and 0.19 mg per mg of fraction, respectively, their individual contributions correspond to 81.7% and 10.8% inhibition. The combined inhibitory effect of 92.6% aligns closely with the experimentally determined 98% inhibition for the SeFB fraction, further supporting the consistency and reliability of the calculated values.\nThe results obtained through SwissTargetPrediction ( Figure 9 ) reinforce the idea that the metabolites present in  S. elegans  do not act independently but rather as part of a network of interactions with nuclear receptors, lipid metabolism enzymes, and G protein-coupled receptors involved in inflammation (PTGER2, PTGER4, and PTGDR) [ 44 ]. This integrative perspective suggests that the plant may simultaneously modulate metabolic, endocrine, and immunological pathways, conferring a multifunctional therapeutic profile that is particularly relevant in the context of chronic and metabolic inflammatory diseases.\nTaken together, the experimental and computational findings support that the SeAcOEt of  S. elegans  could be act as anti-inflammatory probably and according to prediction analysis of the COX-2/NF-κB-dependent eicosanoid cascade and the activation of PPAR nuclear receptors. The isolated compounds—particularly  4 ,  3 ,  5 , and the TM  1/2 —could be act complementarily by regulating both local pro-inflammatory mechanisms and systemic processes related to metabolic and hormonal homeostasis [ 43 , 45 ].\nThese results open a new perspective for pharmacological research on  S. elegans , highlighting its potential as a source of natural anti-inflammatory agents with possible applications in metabolic, cardiovascular, neurodegenerative, and hormone-dependent oncological diseases [ 20 ].\nHowever, several limitations warrant consideration. The study was conducted primarily in an acute inflammation model (TPA-induced edema), which, although validated, may not fully represent chronic or systemic inflammatory conditions. Additionally, the target predictions, while informative, require experimental validation through receptor-binding assays, gene expression analyses, and refined molecular docking. The possibility that other molecular mechanisms—such as COX-2 inhibition and cytokine modulation, among others—contribute to the activity of the evaluated compounds cannot be ruled out; further experiments are required to investigate this. The lack of pharmacokinetic and toxicity data for the isolated compounds also limits the immediate translational applicability of the findings.\n\nMelting points were obtained on a Thermo Scientific IA9000 series (Waltham, MA, USA) melting point apparatus and were uncorrected. All NMR spectra were recorded on Varian INOVA-400 (Varian, Palo Alto, CA, USA) at 400 MHz for  1 H NMR, NOESY,  1 H- 1 H COSY, HSQC and HMBC, and 100 MHz for  13 C NMR and DEPT in CDCl 3 . Chemical shifts are reported in ppm relative to TMS.\nHPLC analysis was performed on a Waters 2695 (Milford, MA, USA) separation module system equipped with a Waters 2996 photodiode array detector and Empower Chromatographic Manager version 1 software (Mildford, MA, USA). GC-MS equipment used for the identification of the compounds was an Agilent Technology 6890 plus Gas Chromatograph (Santa Clara, CA, USA), coupled to a 5973N mass spectrometer with a simple quadrupole analyzer, with the Electron Impact (IE) ionization mode at 70 eV [ 38 ]. The equipment has an automatic injection system. Compounds in a mass range of 30 to 500 Dalton can be optimally detected. Volatile and non-thermolabile organic compounds were separated on a HP 5MS capillary column (25 m long, 0.2 mm i.d., with 0.3 µm film thickness). Oven temperature was set at 40 °C for 2 min and then programmed from 40–260 °C at 10 °C/min and maintained for 20 min at 260 °C. Mass detector conditions were as follows: interphase temperature 200 °C and mass acquisition range, 20–550. Injector and detector temperatures were set at 250 and 280 °C, respectively. Splitless injection mode was carried out with 1 µL of each fraction (3 mg/mL solution). The carrier gas was helium at a flow rate of 1 mL/min.\nThe aerial parts of  Salvia elegans  (6 kg) were collected in Ozumba, the state of México, 19°02′20.58″ north latitude and 98°47′42.38″ longitude west. The voucher specimen of this material (2056) was deposited in the Botanical Garden and Museum of Traditional Medicine and Herbal Medicine of INAH Morelos, identified by the taxonomists Margarita Aviles and Macrina Fuentes Mata.\nThe fresh material was dried in the shade, in a ventilated place and at a temperature of 25 °C. Subsequently, the dry leaves (3 kg) were ground in a pulvex mill and placed in a glass container for extraction with ethyl acetate 15 L (Merck, Darmstadt, Germany), allowing to rest for 24 h at room temperature. This process was carried out in triplicate. The ethyl acetate extract was filtered and concentrated in a rotary evaporator Heidolph Laborota G3 (Schwabach, Germany), under reduced pressure at 45–50 °C until completely dry, which was frozen with the help of a lyophilizer Labconco (Saint Louis, MO, USA) to give 330 g of the SeAcOE extract.\nEthyl acetate extract (200.3 g) was adsorbed on silica gel and applied to a glass column (10 × 50 cm) packed with normal phase silica gel (400.5 g, 70-230 mesh, Merck). An n-hexane/ethyl acetate/methanol gradient was used as the mobile phase for column elution. A total of 500 mL aliquots were collected and concentrated using a rotary evaporator under reduced pressure, yielding 61 fractions. These were grouped into 17 fractions (SeF1–SeF17) based on compound similarity. Thin-layer chromatography analysis of the fractions allowed for their regrouping into three subfractions (SeFA, SeFB and SeFC) for evaluation in the TPA-induced edema model.\nOne of the active fractions (SeFA) was analyzed by gas masses (GC-MS) and rosifoliol  1  and agarospirol ( 2 ) were identified [ 19 ].\nSeFB fraction (5g) was adsorbed silica gel and applied to a column of silica gel (150 g, 70-230 mesh, Merck, Darmstadt, Germany). A gradient of  n -hexane/ethyl acetate/methanol was used to elute the column, collecting 24 fractions of 200 mL each. Fractions were grouped according to their similarity in TLC in 20 fractions (SeR1-SeR20).\nFractions SeR5 to SeR7 showed a single spot on TLC. HPLC and mass analysis allowed the identification of ursolic acid (3). The SeR11-SeR15 fractions (626.6 mg) were pooled and purified on a reversed-phase column chromatography (10 g, RP-18, 40–63 µm, Merck, Darmstadt, Germany) with a water/acetonitrile mobile phase in a gradient system starting with 70:30 and increasing polarity by 10%. A total of 10 mL samples were collected, yielding 41 fractions. Fractions 33–36 (SeFB) showed a single spot on TLC and were identified by one- and two-dimensional NMR analysis as a diterpene called 7α-hydroxysandaracopimaric acid ( 4 ).\nHPLC analysis was performed with a column LiChrospher ®  (Rp18, 20 × 5 μm, 50 μm) (Merck KGaA, Darmstadt, Germany), at a flow rate of 1.20 mL/min, and a gradient system water/acetonitrile (A: B), having the following proportions A: B; 100:0 (0–1 min); 60:40 (2–3 min); 10:90 (4–10 min); 0:100 (11–17 min); and 100:0 (18–20 min). Total running time of samples was 20 min, with 10 μL injection.\nThe detection wavelength was scanned at 190–220 nm. This method was used for ursolic acid ( 3 ) and 7α-hydroxypimaric acid ( 4 ). The retention times (Rt) to compounds  3  and  4  were 13.54 and 9.03 min, respectively.\nSeFC fraction (8 g) was separated by using a chromatographic column with silica gel (200 g, 70-230 mesh, Merck, Darmstadt, Germany), eluting with a solvent mixture with increasing polarity with hexane/ethyl acetate/methanol, collecting 14 fractions of 200 mL each. Fractions 7 and 8 were combined and recrystallized for obtaining solid yellow, which was elucidated by analysis of  1 H and  13 C NMR as jaceosidin ( 5 , 30 mg), a known flavonoid. In fraction 10, the flavonoid known as Isosakuranetin-5-O-rutinoside ( 6 , 100 mg) was identified. Spectroscopic data were compared with the literature [ 17 ].\nHPLC analysis was performed with a column SUPERCOSIL TM  LC-F de 25 cm × 4.5 mm, 5 μm (Merck KGaA, Darmstadt, Germany), at a flow rate of 0.90 mL/min, and a gradient system water-TFA 0.5% and acetonitrile (A: B) having the following proportions: A: B 100:0 (0–1 min); 95:5 (2–3 min); 70:30 (4–20 min); 50:50 (21–23 min); 20:80 (24–25 min); 0:100 (26–27 min); and 100:0 (28–30 min). The total running time of samples was 30 min, with 10 μL injection. The detection wavelength was scanned at 345 nm. The retention times (Rts) of compounds  5  and  6  were 19.2 and 14.6 min, respectively.\nAll procedures were conducted in accordance with Official Mexican Norm (NOM-062-ZOO-1999) [ 46 ], regarding technical specifications for the production, care, and use of laboratory animals, and the Guide for the Care and Use of Laboratory Animals and the international ethical guidelines for the care and use of laboratory animals. ICR healthy male albino mice weighing between 25 and 30 g (Harlan, Mexico City, Mexico) were used for this assay. All animals were housed eight per cage and maintained under laboratory conditions at 25 °C, with a normal 12 h:12 h light/dark schedule (lights on at 7:00 a.m.) and free access to water and food (pellets, Envigo rodent lab diet, Indianapolis, IN, USA). The mice were allowed 3 weeks to adapt to the laboratory environment prior to the trial period. Experiments were carried out between 8:00 a.m. and 12:00 p.m. This research study was approved by the ethical committee of the Mexican Social Security Institute (R-2023-1702-010). Minimum number of animals and minimum duration required to obtain consistent data were employed.\nThe isolated compounds and fractions were evaluated in the anti-inflammatory assay, which was carried out following the method described by Payá [ 47 ]. A total of 60 animals were randomly distributed into 10 groups of 6 mice each; they were separated into cages for technician personnel who did not do the test. In our experience, this sample size allows the reproducibility of the assay and adequate statistical management. Each group received 12-O-Tetradecanoylphorbol-13-acetate (TPA −2.5 μg) (Sigma-Aldrich, Darmstadt, Germany) dissolved in acetone (20 μL), which was applied on the internal and external surface on the right ear to cause edema. Doses of 1 mg/ear of each treatment INDO, SeAcOEt, SeFA, SeFB, SeFC, 7α-hydroxypimaric ( 4 ) acid, isosakuranetin-5-O-rutinoside ( 6 ), and mixture of agarospirol/rosifoliol ( 1 / 2 ) were applied to the ear of each mouse. All treatments were dissolved in acetone and applied topically, 10 min before administration of TPA. Mice were sacrificed by overdoses of sodium pentobarbital and after cervical dislocation, in the 6 h at the start of the assay. Subsequently circular sections of 6 mm diameter were obtained from both ears: one with inflammation with TPA (t) and without TPA (nt). With the weights of each tissue section, we calculated the percentage inhibition of inflammation. Percentage of inhibition was obtained using expression below: Inhibition % = (Δw control − Δw treatment/Δw) × (100), \nwhere\nwt is the weight of the section of the treated ear;\nwnt is the weight of the section of the non-treated ear.\nThe evaluation of the anti-inflammatory activity of  Salvia elegans  compounds was carried out using a cell line of macrophages (RAW-Blue TM  cells, InvivoGen, Catalog code: Raw-Sp. San Diego, CA, USA). These cells have a reporter gene that expresses an alkaline phosphatase (SEAP). The enzyme is under the control of an inducible promoter, by the transcription factors NF-κB and AP-1. In addition, the SEAP that is secreted into the culture medium catalyzes the enzymatic transformation of the substrate, which allows the reaction to be followed by using a colorimeter.\nThe cells were grown and maintained in DMEM, according to the manufacturer’s instructions (Dulbecco’s modified Eagle’s Medium) (Waltham, MA, USA) at 37 °C and 5% of atmosphere CO 2 . The assay was carried out in the following manner: the cells were inoculated in 24 well plates with 1 × 10 5  cells/well and were incubated for six hours; subsequently, the macrophages were stimulated with 20 ng/mL of lipopolysaccharide (LPS) (Sigma-Aldrich, Darmstadt, Germany) and, at the same time, increasing amounts (1.25, 2.50, 5.00, 10.00, 20.00, 40.00 and 80.00 μg/mL) of the mixture of terpenes (rosifoliol/agarospirol  1/2 , TM) or 7α-hydroxysandaracopimaric acid ( 4 ) were administered, and the cells were incubated for 12 h. At the end of the incubation period, 50 μL of culture medium was collected, on which the alkaline phosphatase activity was determined using the QUANTI-Blue reagent (InvivoGen) (San Diego, CA, USA) to quantify the enzymatic activity. There were three independent replicates ( n  = 4). Experiments were repeated on different days and at different passages to account for biological variation.\nThe chemical structures of  1 ,  2 ,  3 ,  4 ,  5 , and  6  were obtained from previously reported structural data and converted into canonical SMILES format for use with PUBCHEM (pubchem.ncbi.nlm.nih.gov). Subsequently, target prediction was performed using the SwissTargetPrediction web server ( https://www.swisstargetprediction.ch/  accessed on 25 January 2026), with Homo sapiens selected as the reference organism. Predicted targets were ranked by probability score ( Appendix A ).\nData from TPA and cell culture assays were analyzed by ANOVA, with a post-test Dunnett in comparison with vehicle group; any experimental unit was excluded, with statistical differences established at *  p  < 0.05, by using the SPSS 20.0 program.\n\nThe present study provides the first comprehensive pharmacological and phytochemical characterization of the ethyl acetate extract of  Salvia elegans , integrating chemical profiling with complementary in vivo, in vitro, and computational approaches. The results demonstrate that the extract exhibits significant local anti-inflammatory activity, while bioassay-guided fractionation identified SeFB as the most active fraction, enriched in ursolic acid and the newly identified diterpene 7α-hydroxysandaracopimaric acid.\nDetailed spectroscopic analysis established, to the best of our knowledge, the first report of 7α-hydroxysandaracopimaric acid in  S. elegans , thereby expanding the phytochemical knowledge of this medicinal species. Pharmacological evaluation further demonstrated that the terpene mixture (rosifoliol/agarospirol, TM) and 7α-hydroxysandaracopimaric acid reduced NF-κB/AP-1-dependent SEAP reporter activity in LPS-stimulated RAW-Blue™ macrophages, supporting their contribution to the anti-inflammatory activity of the extract. However, the markedly higher activity observed for SeFB than for compound  4  alone suggests that the pharmacological effect of the extract is more likely explained by the combined contribution of multiple metabolites rather than by a single active constituent.\nComputational target prediction suggested that several of these metabolites may interact with molecular targets involved in inflammatory signaling, including prostaglandin receptors, nuclear receptors, and lipid metabolism-related proteins. Nevertheless, these predictions should be regarded as hypothesis-generating, and they require experimental validation before mechanistic conclusions can be drawn.\nOverall, this study provides pharmacological evidence supporting the traditional use of  S. elegans  for inflammatory conditions and establishes a solid foundation for future investigations aimed at defining the individual and combined contributions of its major metabolites, validating their molecular targets, and elucidating the mechanisms underlying the anti-inflammatory activity of this medicinal species.","source_license":"CC-BY-4.0","license_restricted":false}